Abstract
Autoimmune hemolytic anaemia (AIHA) has traditionally been classified based on the temperature sensitivity of the autoagglutinins as warm (WAIHA), cold (CAIHA) and mixed type. Autoagglutinin may be of IgG or IgM type. The present prospective study was conducted to evaluate the profile of clinical picture, severity of haemolysis, treatment response of steroid. This study on patients of adult primary AIHA was conducted by taking complete history followed by detail physical examination. Laboratory investigations were performed to establish haemolytic anaemia and to assess severity of haemolysis. Immunehematological work up including blood grouping, direct antiglobulin test (DAT), IAT, antibody screening, adsorption elution was performed to diagnose type of AIHA. All cases were followed up to assess the response to prednisolone. All the data were collected and analysed by SPSS 19. Out of 62 primary AIHA cases, female were affected more than male (41:21). WAIHA is most common type (42, 67.8%) followed by mixed (20.9%) and cold AIHA (11.3%). Severity of haemolysis showed significant correlation with the DAT strength and not with type of AIHA. (P < 0.05) On oral prednisolone, 22 cases attended complete remission, while relapse, drug dependency and partial remission was achieved in 13, 9, 3 cases respectively. Severity of haemolysis in AIHA is directly related with DAT strength. WAIHA is most common type and can be managed with oral prednisolone (cr 45.2%), without red cell transfusion in most of cases. Mixed type AIHA cases were presented mostly with severe haemolysis, with minimum therapeutic response to prednisolone and maximum relapse/drug dependency.
Similar content being viewed by others
References
De Gruchy GC (1989) The haemolytic anaemias. In: Firkin FC, Chesterman CN, Penington DG, Rush BM (eds) De Gruchy's clinical haematology in medical practice, 5th edn. Blckwell Science Ltd, Edinburgh, pp 172–215
Dacie JV (1992) Autoimmunehemolytic anemia: pathogenesis. Thehemolytic anemia. 3rd edn. Churchill Livingstone, London, pp 392–451
Packman CH (2008) Hemolytic anemia due to warm autoantibodies. Blood Rev 22(1):17–31
Valent P, Lechner K (2008) Diagnosis and treatment of autoimmune hemolytic anemia in adults: a clinical review. Wien KlinWochenschr 120:136–151
Petz LD, Garratty G (1971) Classification and clinical characterization of Autoimmune hemolyticanemias. In: Acquired Immune HemolyticAnemias, 1st edn., p 28, Churchill Livingstone, New York
Lechner K, Jager U (2010) How I treat autoimmune hemolytic anemia in adults. Blood 16:1831–1838
Birgens H, Frederiksen H, Hasselbalch HC et al (2013) A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol 163(3):393–399
Mishra D, Sahoo D, Ray GK, Panigrahi R (2018) Resolving serological blood group discrepancy and providing transfusion support in a patient of mixed autoimmune haemolytic anemia. HematoInt J 2(1):118
Wikman A, Axdorph U, Gryfelt G, Gustafsson L, Bjorkholm M, Lundhal J (2005) Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to invivohemolysis. Ann Hemato 84:150–158
Wheeler CA, Calhoun L, Blackall DP (2004) Warm reactive autoantibodies: clinical and serological correlation. Am J clinical Patho 122:680–685
Das SS, Zaman RU, Safi M (2014) Incompatible blood transfusion: challenging yet life saving in the management of acute sever autoimmune haemolytic anemia. Asian J of Trans Scie 8(2):105–108
Garratty G, Petz LD (2002) Approaches to selecting blood for transfusion to patients with autoimmune hemolytic anemia. Transfusion 42:1390–1392
Sudulagunta SR, Kumbhat M, Sudulagunta MB (2017) Warm Autoimmune Hemolytic Anemia: Clinical Profile and Management. J Hemato 6(1):12–20
Pirofsky B (1976) Clinical aspects of autoimmune hemolytic anemia. Seminars Hematolo 13:251
Das SS, Nityanand S, Choudhary R (2009) Clinical and serological characterization of autoimmune hemolytic anemia in a tertiary care hospital in North India. AnnHemato 88:727–732
Allgood JW, Chaplin HJ (1967) Idiopathic acquiredautoimmunehemolytic anemia. Am J Med 43:254
Schreiber AD, Herskovitz BS, Goldwein M (1977) Low-titer cold hemagglutinin disease, mechanism of haemolysis and response to corticosteroid. N Eng J Medicine 296:1490–1494
Bianco C, Grifin FM, Silverstein SC (1975) Studies of the macrophage complement receptor. J Exp Med 141:1278
Mahapatra S, Sahoo D, Patajoshi S, Sahu A, Parida P, Mishra S (2012) Distribution and prevalence of ABO and Rh phenotype blood groups in eastern India. J Pharm Biomed Sci 04:712–714
Mishra D, Parida P, Mahapatra S, Sahu BB (2018) Resolving blood group discrepancy in patients of a tertiary care centre in Odisha, India. Int J Res Med Sci 6(2):2348–2353
Settipane GA, Pudupakkam RK, McGowan JH (1978) Corticosteroid effect on immunoglobulins. J Allergy ClinImmunol 62(3):162–166
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest.
Ethical Approval
Approved by the institutional ethical committee.
Informed Consent
Informed consent was obtained from all patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ray, G.K., Mishra, D., Jena, R.K. et al. Clinical Profile and Severity of Hemolysis in Adult Patients of Primary Autoimmune Hemolytic Anemia and Their Response to Steroid: A Prospective Cohort Study from Single Institution. Indian J Hematol Blood Transfus 37, 119–125 (2021). https://doi.org/10.1007/s12288-020-01326-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-020-01326-4